Pharmacogenomics (PGx) is a key component of personalised medicine. The purpose of this bulletin is to introduce PGx to medicines committees and working groups and provide considerations for embedding PGx testing into medicines governance structures and processes, supporting the safe and effective use of medicines.

This document was updated on 5th of February 2026 with minor text revisions to improve clarity.